Sumitomo Pharma DNPUF Stock
Sumitomo Pharma Price Chart
Sumitomo Pharma DNPUF Financial and Trading Overview
| Sumitomo Pharma stock price | 10.5 USD |
| Previous Close | 8.41 USD |
| Open | 10.5 USD |
| Bid | 8.51 USD x 10000 |
| Ask | 9.36 USD x 30000 |
| Day's Range | 10.5 - 10.5 USD |
| 52 Week Range | 8.41 - 19.2 USD |
| Volume | 118 USD |
| Avg. Volume | 60 USD |
| Market Cap | 3.77B USD |
| Beta (5Y Monthly) | 0.457 |
| PE Ratio (TTM) | 4.9470587 |
| EPS (TTM) | 1.69 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | March 30, 2023 |
| 1y Target Est | N/A |
DNPUF Valuation Measures
| Enterprise Value | 87.79B USD |
| Trailing P/E | 4.9470587 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.007946027 |
| Price/Book (mrq) | 1.4676062 |
| Enterprise Value/Revenue | 0.185 |
| Enterprise Value/EBITDA | 1.285 |
Trading Information
Sumitomo Pharma Stock Price History
| Beta (5Y Monthly) | 0.457 |
| 52-Week Change | -6.24% |
| S&P500 52-Week Change | 18.35% |
| 52 Week High | 19.2 USD |
| 52 Week Low | 8.41 USD |
| 50-Day Moving Average | 8.8 USD |
| 200-Day Moving Average | 12.1 USD |
DNPUF Share Statistics
| Avg. Volume (3 month) | 60 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 448.59M |
| Float | 238.43M |
| Short Ratio | N/A |
| % Held by Insiders | 48.83% |
| % Held by Institutions | 21.60% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2026 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | March 31, 2027 |
Profitability
| Profit Margin | 23.72% |
| Operating Margin (ttm) | 13.70% |
| Gross Margin | 54.99% |
| EBITDA Margin | 14.39% |
Management Effectiveness
| Return on Assets (ttm) | 3.92% |
| Return on Equity (ttm) | 38.52% |
Income Statement
| Revenue (ttm) | 474.79B USD |
| Revenue Per Share (ttm) | 1166.92 USD |
| Quarterly Revenue Growth (yoy) | 19.90% |
| Gross Profit (ttm) | 261.08B USD |
| EBITDA | 68.34B USD |
| Net Income Avi to Common (ttm) | 112.66B USD |
| Diluted EPS (ttm) | 1.7 |
| Quarterly Earnings Growth (yoy) | 51.70% |
Balance Sheet
| Total Cash (mrq) | 76.64B USD |
| Total Cash Per Share (mrq) | 170.85 USD |
| Total Debt (mrq) | 160.66B USD |
| Total Debt/Equity (mrq) | 39.32 USD |
| Current Ratio (mrq) | 1.212 |
| Book Value Per Share (mrq) | 5.73042 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 64.46B USD |
| Levered Free Cash Flow (ttm) | 80.34B USD |
Profile of Sumitomo Pharma
| Country | United States |
| State | N/A |
| City | Osaka |
| Address | 2-6-8 Doshomachi |
| ZIP | 541-0045 |
| Phone | 81 6 6203 5321 |
| Website | https://www.sumitomo-pharma.com |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Sumitomo Pharma Co., Ltd. Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia. It offers therapeutic agents for parkinson's disease, type 2 diabetes, uterine fibroids and endometriosis, overactive bladder, and pediatric congenital athymia. The company also provides atypical antipsychotic, generic products, antiepileptic, atypical antipsychotic, and carbapenem antibiotic. In addition, it offers veterinary medicines, medical devices, etc. The company has collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company was formerly known as Sumitomo Dainippon Pharma Co., Ltd. and changed its name to Sumitomo Pharma Co., Ltd. in April 2022. The company was incorporated in 1897 and is headquartered in Osaka, Japan. Sumitomo Pharma Co., Ltd. is a subsidiary of Sumitomo Chemical Company, Limited.
Q&A For Sumitomo Pharma Stock
What is a current DNPUF stock price?
Sumitomo Pharma DNPUF stock price today per share is 10.5 USD.
How to purchase Sumitomo Pharma stock?
You can buy DNPUF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Sumitomo Pharma?
The stock symbol or ticker of Sumitomo Pharma is DNPUF.
Which industry does the Sumitomo Pharma company belong to?
The Sumitomo Pharma industry is Drug Manufacturers - Specialty & Generic.
How many shares does Sumitomo Pharma have in circulation?
The max supply of Sumitomo Pharma shares is 448.59M.
What is Sumitomo Pharma Price to Earnings Ratio (PE Ratio)?
Sumitomo Pharma PE Ratio is 6.21301750 now.
What was Sumitomo Pharma earnings per share over the trailing 12 months (TTM)?
Sumitomo Pharma EPS is 1.69 USD over the trailing 12 months.
Which sector does the Sumitomo Pharma company belong to?
The Sumitomo Pharma sector is Healthcare.
